Skip to main content
. Author manuscript; available in PMC: 2020 May 28.
Published in final edited form as: Biomater Sci. 2019 May 28;7(6):2218–2240. doi: 10.1039/c9bm00238c

Table 3.

Silica materials synthesized from discrete segment and droplet microreactors.

Microchannel type Material type Material size Material shape Porous
type
Bioapplication
Area
Ref by Year
Winding SiO2 277–540 nm Sphere Solid N/A 200439
Winding SiO2 200–300 nm Sphere Solid N/A 200440
Winding SiO2@TiO2 ~250 nm Sphere Solid N/A 200781
Cross-Winding SiO2 ~15–35 μm Sphere Mesopore (>5 nm) N/A 200882
T junction SiO2 0.25–0.5 mm (Sphere); 1.1×2.3–4.7 mm (Rod) Sphere; Rod Solid N/A 200883
Cross junction SiO2 ~1 μm Sphere Mesopore (6.4 nm) N/A 200884
T junction SiO2 ~100 μm Sphere Hollow N/A 200985
Coflow and flow-focusing SiO2 ~50 μm Nonsphere polygon Hollow N/A 200986
Cross junction SiO2 130 μm Sphere Hollow; mesopore (2 nm) Iodine adsorption 201087
Cross junction SiO2-Chitosan 250 μm Sphere Macropore BSA immobilization 201088
Coflow-Winding SiO2 1–5 μm Sphere Mesopore (4.8 nm) N/A 201089
Coflow-Winding SiO2 1–15 μm Sphere Mesopore (4.8 nm) N/A 201090
Flow-focusing QDs@SiO2 ~5 μm Sphere Hollow Ultrasound image; lysozyme immobilization 201091
Coflow and flow-focusing SiO2 29 μm Sphere Hollow N/A 201092
T junction-Winding SiO2@Au 177–260 nm Sphere Solid N/A 201093
Y junction-cross junction SiO2 63 nm Sphere Solid N/A 201146
Flow-focusing SiO2 7–50 μm Doughnut Solid N/A 201194
Coflow Chitosan@TS-1 200–600 μm Sphere Macropore N/A 201195
Coflow SiO2-ETPTA@Ag 77 μm Sphere Solid BT SERS detection 201196
Coflow SiO2 100–200 μm Sphere Hollow; mesopore (2–38 nm) N/A 201197
Coflow SiO2@TiO2 100–300 μm Sphere Solid N/A 201198
Coflow Fe2O3@SiO2@Pt 100 μm Sphere Mesopore (18 nm) IBA oxidation 201248
Flow-focusing SiO2-FITC 50–350 nm Sphere Solid N/A 201299
Flow-focusing SiO2 1.4–14.6 μm Sphere Hollow; mesopore (7.44 nm) N/A 2012100
Coflow SiO2-HDDA ~0.5 μm Patchy Mesopore N/A 2012101
Cross junction SiO2 7.7 μm Sphere Mesopore (3.4–6 nm) N/A 2013102
Flow-focusing SiO2-lipid ~25 μm Sphere Mesopore (13.4 nm) FFB, FSM, MTX, and RTD drug loading 2013103
Coflow SiO2-Chitosan 420 μm Sphere Mesopore (<5 nm) Cu(II) adsorption 2013104
Coflow SiO2-Fe3O4 150 μm Sphere Mesopore Optical encoding 2013105
T junction SiO2@Au 230 nm Sphere Solid N/A 2013106
T junction SiO2 ~100 μm Raspberry-like Solid N/A 2013107
T junction SiO2 90–185 μm Sphere; filbert-like Solid; hollow N/A 2014108
Coflow and flow-focusing SiO2 ~200 μm Sphere; disk Mesopore N/A 2014109
Coflow SiO2-PEGDA ~200–1000 μm Rod; cuboid; disk Solid Optical encoding 2014110
Coflow and flow-focusing SiO2-Dextran 150–400 nm Sphere Mesopore PTX, SFN, and MTX drug loading 2015111
T junction SiO2@Fe2O3 ~100 nm Sphere Solid N/A 2015112
T junction SiO2@Au ~175 nm Sphere Solid N/A 2015113
Coflow and flow-focusing SiO2-PEGDA ~100–150 nm (diameter) Fiber Macropore N/A 2016114
Y junction and T junction SiO2-Cell 1.3–2.9 mm Sphere Solid E. coli encapsulation 2016115
T junction SiO2; Au@SiO2 ~100–350 nm Sphere Solid (Au@SiO2); Mesopore (SiO2) N/A 2016116
Slit interdigital SiO2-FITC 10–65 nm Sphere Solid N/A 2017117
T junction SiO2-Fe3O4 260 μm Sphere Mesopore OTA adsorption 2017118
Flow-focusing SiO2 ~10–30 μm Sphere Hollow; mesopore (5.9 nm) N/A 2017119
T junction SiO2 187 μm Sphere Mesopore-macropore DEX drug loading 2018120
Cross junction SiO2-PCL ~50 μm Sphere Solid; macropore SOD and CAT immobilization 2018121
Coflow SiO2-PLGA ~200 μm Sphere Hollow; mesopore DFO drug loading 2018122
Cross junction PDT@SiO2 ~90 μm Sphere Solid N/A 2018123

Abbreviations: BSA: Bovine serum albumin; BT: Benzenethiol; CAT: Chloramphenicol acetyltransferase; DEX: Dexamethasone; DFO: Deferoxamine; ETPTA: Ethoxylated trimethylolpropane triacrylate; FFB: Fenofibrate; FITC: Fluorescein isothiocyanate; FSM: Furosemide; HDDA: 1,6-hexanediol diacrylate; IBA: 4-isopropyl benzaldehyde; MTX: Methotrexate; N/A: Not Applicable; OTA: Ochratoxin A; PCL: Polycaprolactone; PDT: Poly(1,10-decanediol dimethacrylate-co-trimethoxysillyl propyl methacrylate); PEGDA: Poly(ethylene glycol) diacrylate; PLGA: Poly(lactic-co-glycolic acid); PTX: Paclitaxel; QDs: Quantum dots; RTD: Ranitidine; SERS: Surface-enhanced Raman scattering; SFN: Sorafenib; SOD: Superoxide dismutase; TS-1: Titanium silicate molecular sieves.